多发性骨髓瘤分子的生物学研究进展
摘要
多发性骨髓瘤（MM）是一种异质性较强的疾病，影响患者的预后和对治疗的反应。MM存在多种染色体易位，导致MM细胞信号通路异常，促使疾病发生及发展。研究信号分子在MM发生及发展中的作用，有利于开发MM的靶向治疗药物和对MM的危险分层治疗。笔者就MM分子生物学的研究现状进行综述。
出处
《国际输血及血液学杂志》
CAS
2012年第6期508-510,共3页
International Journal of Blood Transfusion and Hematology
基金
国家自然科学基金（81172252）
参考文献21
-
1Hideshima T. Chauhan D. Kiziltepe T. et al. Biologic sequelae of I { kappa} B kinase (IKK) inhibition in multiple myeloma: therapeutic implications. Blood. 2009. 113(21) :5228-5236.
-
2Mitsiades CS. Mitsiades NS. Munshi NC. et al. The role of the bone microenvironment in the pathophysiology and therapeutic management of multiple myeloma: interplay of growth factors. their receptors and stromal interactions. Eur 1 Cancer. 2006. 42 (1): 1564-1573.
-
3Walsby E1. Pratt G. Hewamana S. et al. The NF-kappaB inhibitor LC-1 has single agent activity in multiple myeloma cells and synergizes with bortezomib. Mol Cancer Ther , 2010. 9(6): 1574-1582.
-
4Pratilas CA. Solit DB. Targeting the mitogen-activated protein kinase pathway, physiological feedback and drug response. Clin Cancer Res. 2010. 16(3) ,3329-3334.
-
5Haagenson KK. Wu GS. Mitogen activated protein kinase phosphatases and cancer. Cancer Bioi Ther , 2010. 9 (5), 337- 340.
-
6Pingali SR. Haddad RY. Saad A. Current concepts of clinical management of multiple myeloma. Dis Mon. 2012. 58 (4),195- 207.
-
7Laplante M. Sabatini DM. mTOR signaling in growth control and disease. Cell. 2012. 149(2) :274-293.
-
8Sheppard K. Kinross KM. Solomon B. et al. Targeting PI3 kinase/ AKT /mTOR signaling in cancer. Crit Rev Oncog , 2012. 17(1) :69-95.
-
9Gera 1. Lichtenstein A. The mammalian target of rapamycin pathway as a therapeutic target in multiple myeloma. Leuk Lymphoma. 2011. 52(0),1857-1866.
-
10Sansone P. Bromberg 1. Targeting the interleukin-6/1ak/stat pathway in human malignancies. 1 Clin Oncol , 2012. 30 ( 9) : 1005-1014.
-
1陈世伦.多发性骨髓瘤的预后评估与危险分层治疗[J].白血病．淋巴瘤,2009,18(9):517-518.
-
2主鸿鹄,黄晓军.我如何治疗t（8；21）急性髓系白血病[J].中华血液学杂志,2017,38(1):6-9. 被引量：7
-
3李丽梅,阿茹娜,张继英,金阿荣.急性早幼粒细胞白血病的分层治疗观察[J].中国临床保健杂志,2015,18(2):193-194. 被引量：2
-
4耿传营,陈文明.新诊断多发性骨髓瘤的危险分层治疗：来自2012年美国临床肿瘤学会年会的报道[J].白血病．淋巴瘤,2012,21(7):390-392.
-
5主鸿鹄,黄晓军.微小残留病监测指导下的危险分层治疗提高t（8；21）急性髓性白血病的疗效[J].中华内科杂志,2014,53(2):140-140. 被引量：2
-
6孙晓非,王娟.儿童非霍奇金淋巴瘤最新国际分期及疗效评估标准[J].中国小儿血液与肿瘤杂志,2016,21(4):169-173. 被引量：5
-
7牛巧红,王俊兰,赵志强,张巧花.三种化疗方案治疗套细胞淋巴瘤的疗效及新预后指数分析[J].白血病．淋巴瘤,2012,21(11):694-696. 被引量：1
